Antoni Vilaseca

6PUBLICATIONS
11CO-AUTHORS
Medical biotechnology diagnostics (incl. biosensors)Predictive and prognostic markersLiquid biopsiesPharmacogenomicsEmergency medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 28, 2026
Correction: Pérez et al. Biomarker-Based Nomogram to Predict Neoadjuvant Chemotherapy Response in Muscle-Invasive Bladder Cancer. Biomedicines 2025, 13, 740.

|Mar 28, 2025
Biomarker-Based Nomogram to Predict Neoadjuvant Chemotherapy Response in Muscle-Invasive Bladder Cancer.

Meritxell Pérez, Juan José Lozano, Mercedes Ingelmo-Torres

|Nov 09, 2024
The Role of Bladder-Washing Cytology as an Adjunctive Method to Cystoscopy During Follow-Up for Low-Grade TaT1 Non-Muscle-Invasive Bladder Cancer.

Enric Carbonell, Clàudia Mercader, Héctor Alfambra

|Aug 01, 2024
Early Identification and Management of Patients with Rash on Apalutamide.

Alison J Birtle, Luigi Formisano, Vincent Descamps

|Jun 18, 2024
Real-world study: Impact of multidisciplinary management of apalutamide-associated adverse events in prostate cancer.

Julián Córdoba Sánchez, Inés Monge-Escartín, Javier Gil

|Aug 26, 2022
The Effect of Adverse Surgical Margins on the Risk of Biochemical Recurrence after Robotic-Assisted Radical Prostatectomy.

Enric Carbonell, Roger Matheu, Maria Muní

Pageof 1

Frequent Collaborators

2 joint publications

Antoine G van der Heijden

2 joint publications

Antonio Coy

2 joint publications

Begoña Mellado

2 joint publications

Maria J Ribal